COMPANY

Affinity Biosensors

HQ: Santa Barbara, CA source · affinitybio.com ↗ · West Coast

FDA-cleared device company

Location: Santa Barbara, CA · source · Sep 16, 2026

Profile checked Oct 10, 2026

2FDA records (2 yrs)

Funding and NIH signals

SEC Form D raise Raised $4.9M (Form D filed Mar 23, 2026; amended Oct 14, 2026). SEC Form D 0001424288-26-000001 (Mar 23, 2026)
Evidence (1 event)
- Mar 23, 2026 · SEC Form D 0001424288-26-000001
  Name of Issuer: AFFINITY BIOSENSORS LLC; CIK: 1424288; Address: Santa Barbara, CA; Submission type: D; Filing date: 2026-03-23; Industry Group: Other; Date of First Sale: 2026-03-20; Types of Securities Offered: Equity, Other (SAFE); Business combination transaction: false; Total Offering Amount: 18000000; Total Amount Sold: 1592385; Federal exemptions: 06b || Name of Issuer: AFFINITY BIOSENSORS LLC; CIK: 1424288; Address: Santa Barbara, CA; Submission type: D/A; Filing date: 2026-05-21; Industry Group: Other; Date of First Sale: 2026-03-20; Types of Securities Offered: Equity, Other (SAFE); Business combination transaction: false; Total Offering Amount: 18000000; Total Amount Sold: 2317385; Federal exemptions: 06b || Name of Issuer: AFFINITY BIOSENSORS LLC; CIK: 1424288; Address: Santa Barbara, CA; Submission type: D/A; Filing date: 2026-07-16; Industry Group: Other; Date of First Sale: 2026-03-20; Types of Securities Offered: Equity, Other (SAFE); Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 2909771; Federal exemptions: 06b || Name of Issuer: AFFINITY BIOSENSORS LLC; CIK: 1424288; Address: Santa Barbara, CA; Submission type: D/A; Filing date: 2026-07-24; Industry Group: Other; Date of First Sale: 2026-03-20; Types of Securities Offered: Equity, Other (SAFE); Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 4004771; Federal exemptions: 06b || Name of Issuer: AFFINITY BIOSENSORS LLC; CIK: 1424288; Address: Santa Barbara, CA; Submission type: D/A; Filing date: 2026-09-16; Industry Group: Other; Date of First Sale: 2026-03-20; Types of Securities Offered: Equity, Other (SAFE); Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 4804771; Federal exemptions: 06b || Name of Issuer: AFFINITY BIOSENSORS LLC; CIK: 1424288; Address: Santa Barbara, CA; Submission type: D/A; Filing date: 2026-10-14; Industry Group: Other; Date of First Sale: 2026-03-20; Types of Securities Offered: Equity, Other (SAFE); Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 4904771; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Oct 27, 2025 FDA FDA 510(k) clearance: LifeScale Gram Negative Kit (LSGN) with the LifeScale AST system — K251875, Oct 27, 2025. Applicant at approval: Affinity Biosensors, LLC. source ↗
Oct 23, 2024 FDA FDA 510(k) clearance: LifeScale Gram Negative Kit (LSGN) with the LifeScale AST system — K241324, Oct 23, 2024. Applicant at approval: Affinity Biosensors, LLC. source ↗

FDA records (last 2 years)

Oct 27, 2025 FDA 510(k) clearance: LifeScale Gram Negative Kit (LSGN) with the LifeScale AST system — K251875, Oct 27, 2025. Applicant at approval: Affinity Biosensors, LLC. source ↗
Oct 23, 2024 FDA 510(k) clearance: LifeScale Gram Negative Kit (LSGN) with the LifeScale AST system — K241324, Oct 23, 2024. Applicant at approval: Affinity Biosensors, LLC. source ↗

Connect

See your connections at Affinity Biosensors on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12